# Specification Quality Checklist: Entropic-FBA infeasible-diagnostic hardening, legacy-test repair, and GECKO dual-residual resolution

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-07-16
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- This is a bug-fix + numerical-characterization feature over existing solver code. Naming the
  affected functions (`entropicFluxBalanceAnalysis`, `solveCobraEP`), the solver backends
  (`mosek`, `pdco`), and status/residual quantities is intentional and unavoidable to keep the
  requirements testable — it identifies the behaviour under repair, not a chosen implementation.
  This is consistent with the constitution's Scientific Computing Constraints (success criteria may
  be "reproducible solver status handling", "objective values within tolerance", "passing CI") and
  with prior repo specs (004, 006, 010). The requirements do not prescribe HOW the fix is coded.
- FR-006 (US3) was the one genuinely open decision. Resolved in the Session 2026-07-16
  clarification: **pursue the fix** (drive the mosek dual residual below `optTol`, including deeper
  cone-dual reconstruction changes if warranted), falling back to characterize-and-tolerate only if
  a correct fix proves infeasible. The acceptance scenarios still cover both outcomes, so FR-006
  remains testable regardless of which the evidence ultimately supports.
- All items pass; no [NEEDS CLARIFICATION] markers remain (16/16 after the clarification session).
